Pekin Hardy Strauss, Inc. Roivant Sciences Ltd. Transaction History
Pekin Hardy Strauss, Inc.
- $744 Million
- Q4 2024
A detailed history of Pekin Hardy Strauss, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Pekin Hardy Strauss, Inc. holds 27,550 shares of ROIV stock, worth $293,958. This represents 0.04% of its overall portfolio holdings.
Number of Shares
27,550
Previous 53,350
48.36%
Holding current value
$293,958
Previous $615,000
47.15%
% of portfolio
0.04%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
329Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$702 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$662 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$510 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$470 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$377 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.52B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...